InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Fenimore Christopher R., Chief Financial Officer. Insider active across 1 company, notably Regeneron Pharmaceuticals, INC.. Aggregated, 26 filings have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €8.3m. Activity tracked since 20 August 2021. The latest transaction was disclosed on 18 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Fenimore Christopher R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
6,283 shares@ US$381.920.0028% mcap5.9% of flowCommon StockSEC:0001697422-26-000002:0
4,599 shares@ US$813.470.0044% mcap9.3% of flowCommon StockSEC:0001697422-26-000002:1
3,027 shares0Common StockSEC:0001697422-25-000004:0
491 shares@ US$730.810.9% of flowCommon StockSEC:0001883850-24-000061:0
2,591 shares0Common StockSEC:0001883850-24-000050:0
228 shares@ US$1,204.790.7% of flowCommon StockSEC:0001883850-24-000045:0
344 shares@ US$950.490.8% of flowCommon StockSEC:0001968202-24-000061:0
5,000 shares@ US$555.676.9% of flowCommon StockSEC:0001968202-24-000041:0
5,000 shares@ US$555.676.9% of flowCommon StockSEC:0001883850-24-000008:0
2,448 shares@ US$856.715.2% of flowCommon StockSEC:0001883850-23-000107:0
456 shares@ US$843.791.0% of flowCommon StockSEC:0001883850-23-000103:0
2,552 shares@ US$856.715.5% of flowCommon StockSEC:0001883850-23-000101:0
474 shares@ US$843.791.0% of flowCommon StockSEC:0001968202-23-000050:0
7,000 shares@ US$399.667.0% of flowCommon StockSEC:0001968202-23-000031:0
2,192 shares@ US$806.474.4% of flowCommon StockSEC:0001883850-23-000060:0
5,000 shares@ US$270.433.4% of flowCommon StockSEC:0001883850-23-000037:0
1,926 shares0Common StockSEC:0001883850-22-000131:0
247 shares@ US$753.280.5% of flowCommon StockSEC:0001883850-22-000117:0
1,844 shares@ US$749.003.8% of flowCommon StockSEC:0001883850-22-000080:0
3,346 shares@ US$724.006.7% of flowCommon StockSEC:0001883850-22-000077:0
2,450 shares@ US$555.674.2% of flowCommon StockSEC:0001708138-22-000039:0
2,000 shares@ US$555.673.4% of flowCommon StockSEC:0001883850-22-000029:0
270 shares@ US$664.340.5% of flowCommon StockSEC:0001708138-21-000106:0
1,859 shares0Common StockSEC:0001883850-21-000022:0
8,719 shares@ US$664.8516.8% of flowCommon StockSEC:0001104659-21-109328:0
25 of 26 declarations
About Fenimore Christopher R.
Fenimore Christopher R. is Directeur Financier at Regeneron Pharmaceuticals, INC. on XNAS. He has made 24 filings in total, and in the recent filings tracked, the transactions are sales for EUR 8284645 between 2021-08-24 and 2025-12-09.
